100
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular risk

, , , , &
Pages 1-12 | Published online: 18 Dec 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Anastasiya Vinokurtseva, Matthew Fung, Erica Ai Li, Richard Zhang, James J Armstrong & Cindy M L Hutnik. (2022) Impact of Inhaled and Intranasal Corticosteroids Exposure on the Risk of Ocular Hypertension and Glaucoma: A Systematic Review and Meta-Analysis. Clinical Ophthalmology 16, pages 1675-1695.
Read now
Yanling Ding, Lina Sun, Ying Wang, Jing Zhang & Yahong Chen. (2022) Efficacy of ICS versus Non-ICS Combination Therapy in COPD: A Meta-Analysis of Randomised Controlled Trials. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 1051-1067.
Read now
Chitra Lal & Charlie Strange. (2019) Evaluating fluticasone furoate + vilanterol for the treatment of chronic obstructive pulmonary disease (COPD). Expert Opinion on Pharmacotherapy 20:9, pages 1075-1085.
Read now
Mohamed Ismail Abdul Aziz, Ling Eng Tan, David Bin-Chia Wu, Fiona Pearce, Gerald Seng Wee Chua, Liang Lin, Ping-Tee Tan & Kwong Ng. (2018) Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3203-3231.
Read now
Gaetano Caramori, Paolo Ruggeri, Paolo Casolari, Kian Fan Chung, Giuseppe Girbino & Ian M. Adcock. (2017) Fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 11:12, pages 955-967.
Read now
Mario Malerba, Alessandro Radaeli, Paolo Montuschi & Jaymin B. Morjaria. (2016) Vilanterol trifenatate for the treatment of COPD. Expert Review of Respiratory Medicine 10:7, pages 719-731.
Read now

Articles from other publishers (4)

Hong Chen, Jian Sun, Qiang Huang, Yongqi Liu, Mengxin Yuan, Chunlan Ma & Hao Yan. (2021) Inhaled Corticosteroids and the Pneumonia Risk in Patients With Chronic Obstructive Pulmonary Disease: A Meta-analysis of Randomized Controlled Trials. Frontiers in Pharmacology 12.
Crossref
Danila Gurgone, Lucy McShane, Charles McSharry, Tomasz J. Guzik & Pasquale Maffia. (2020) Cytokines at the Interplay Between Asthma and Atherosclerosis?. Frontiers in Pharmacology 11.
Crossref
Yuji Oba, Edna Keeney, Namratta Ghatehorde & Sofia Dias. (2018) Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis. Cochrane Database of Systematic Reviews 2018:12.
Crossref
Agnieszka Sliwka, Milosz Jankowski, Iwona Gross-Sondej, Monika Storman, Roman Nowobilski & Malgorzata M Bala. (2018) Once-daily long-acting beta₂-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2018:8.
Crossref